Trials / Completed
CompletedNCT01394185
Effects of Dronabinol (Oral THC) on Cannabis Use
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary alternative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dronabinol 120mg/day | Participants receive 40mg dronabinol 3 times daily |
| DRUG | Placebo | Participants receive placebo |
| DRUG | Dronabinol 240mg/day | Participants receive 80mg dronabinol 3 times daily |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2011-07-14
- Last updated
- 2017-08-03
- Results posted
- 2017-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01394185. Inclusion in this directory is not an endorsement.